Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells. by Hu, Victor H et al.
RESEARCH ARTICLE
Immunohistochemical Analysis of Scarring
Trachoma Indicates Infiltration by Natural
Killer and Undefined CD45 Negative Cells
Victor H. Hu1,2, Philip J. Luthert3, Tamsyn Derrick2,4*, James Pullin3, Helen A. Weiss5,
Patrick Massae2, Tara Mtuy1,2, WilliamMakupa2, David Essex3, David C. W. Mabey4, Robin
L. Bailey4, Martin J. Holland4, Matthew J. Burton1,2
1 International Centre for Eye Health, Department of Clinical Research, Faculty of Infectious and Tropical
Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom, 2 Kilimanjaro
Christian Medical Centre, Moshi, Tanzania, 3 UCL Institute of Ophthalmology, London, United Kingdom,
4 Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene
and Tropical Medicine, London, United Kingdom, 5 Department of Infectious Disease Epidemiology, Faculty
of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United
Kingdom
* tamsyn.derrick@lshtm.ac.uk
Abstract
Introduction
The phenotype and function of immune cells infiltrating the conjunctiva in scarring trachoma
have yet to be fully characterized. We assessed tissue morphology and immunophenotype
of cellular infiltrates found in trachomatous scarring compared to control participants.
Methodology
Clinical assessments and conjunctival biopsy samples were obtained from 34 individuals
with trachomatous scarring undergoing trichiasis surgery and 33 control subjects undergo-
ing cataract or retinal detachment surgery. Biopsy samples were fixed in buffered formalin
and embedded in paraffin wax. Hematoxylin and eosin (H&E) staining was performed for
assessment of the inflammatory cell infiltrate. Immunohistochemical staining of single mark-
ers on individual sections was performed to identify cells expressing CD3 (T-cells), CD4
(helper T-cells), CD8 (suppressor/cytotoxic T-cells and Natural Killer, NK, cells), NCR1 (NK
cells), CD20 (B-cells), CD45 (nucleated hematopoietic cells), CD56 (NK and T-cells), CD68
(macrophages/monocytes) and CD83 (mature dendritic cells). The degree of scarring was
assessed histologically using cross-polarized light to visualize collagen fibres.
Principle Findings
Scarring, regardless of clinical inflammation, was associated with increased inflammatory
cell infiltrates on H&E and CD45 staining. Scarring was also associated with increased CD8
+ and CD56+ cells, but not CD3+ cells, suggestive of a NK cell infiltrate. This was supported
by the presence of NCR1+ cells. There was some increase in CD20+ cells, but no evidence
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for increased CD4+, CD68+ or CD83+ cells. Numerous CD45 negative cells were also seen
in the population of infiltrating inflammatory cells in scarred conjunctiva. Disorganization of
the normal collagen architecture was strongly associated with clinical scarring.
Conclusions/Significance
These data point to the infiltration of immune cells with a phenotype suggestive of NK cells
in conjunctival trachomatous scarring. A large proportion of CD45 negative inflammatory
cells were also present. Future work should seek to understand the stimuli leading to the
recruitment of these cells and their role in progressive scarring.
Author Summary
Trachoma is initiated by repeated infection of the conjunctiva throughout childhood by
the bacterium Chlamydia trachomatis (Ct). Conjunctival inflammation and scarring prog-
ress throughout the lives of many adults even in the absence of Ct infection, causing the
eyelashes to turn inwards (trichiasis) and damage the cornea, resulting in severe pain and
eventually leading to blindness. The factors sustaining the inflammation that drives scar-
ring are not understood and there is no treatment to halt scarring progression. We sought
to define the phenotypes of immune cells infiltrating the conjunctiva during trichiasis.
Eyelid tissue from 34 individuals with trichiasis and 33 control individuals was stained
with dyes or specific antibodies to distinguish immune cell subsets. Increased inflamma-
tory cells were detected in individuals with trichiasis even when clinical signs of inflamma-
tion were not apparent. Staining of immune cell types pointed to an increased infiltration
of natural killer cells in tissue from individuals with trichiasis. These cells may cause tissue
damage through cytokine secretion and cell lysis. Surprisingly, a large number of infiltrat-
ing immune cells lacked the classical immune cell marker CD45. The phenotype and func-
tion of these CD45 negative cells and their role in scarring trachoma warrants further
study.
Introduction
Trachoma starts in childhood with repeated conjunctival infection by Chlamydia trachomatis.
The infection provokes a marked inflammatory response, which can lead to cicatricial sequelae
in later life: conjunctival scarring, entropion, trichiasis, corneal opacity and blindness [1]. Tra-
choma is still a major problem world-wide; the World Health Organization (WHO) currently
estimates it is endemic in 51 countries and is responsible for the visual impairment of 2.2 mil-
lion people, of whom 1.2 million are irreversibly blind [2]. There has been an encouraging
reduction in the number of children with active disease over the last few decades, which is
probably attributable to improved living standards and trachoma control programmes [3].
However, even in areas where the prevalence of C. trachomatis infection has been low for some
time scarring complications still appear to develop and progress [4,5]. This has implications
for trachoma control programmes. There may be a need for more prolonged surveillance and
it is therefore important to better understand the cicatricial disease process.
The pathophysiology of the scarring sequelae of C. trachomatis infection, both in the eye
and genital tract, remains unclear and various models have been proposed [6]. The “immuno-
logical” paradigm suggests that disease is the result of a cell-mediated immune process,
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particularly involving T-cell responses, against specific C. trachomatis antigens [7,8]. The “cel-
lular” paradigm argues that infected epithelial cells are central in causing tissue damage
through the release of pro-inflammatory cytokines, chemokines and growth factors, although
this may also subsequently involve adaptive responses [9,10]. Contemporary studies have sup-
ported the role of innate immunity in the development of scarring complications and indicate
the epithelium may be important in driving these innate processes [4,11,12,13,14].
A number of studies have recently suggested a role for NK cells in trachoma. NK cells repre-
sent around 10–15% of circulating lymphocytes and were historically identified as null cells or
large granular lymphocytes that can lyse target cells without previous sensitisation [15,16].
They are generally considered to be part of the innate immune response as their activity is reg-
ulated through a combination of cytokines, activating and inhibitory receptors and host cell
ligands which enable them to respond rapidly to danger signals such as those triggered by bac-
terial, viral and parasitic infections [17]. They can also have a regulatory role on both innate
and adaptive immunity through the production of cytokines and pro-inflammatory mediators,
notably interferon gamma (IFNγ). A microarray study of active trachoma in children found
increased expression and enrichment of genes involved in NK cell activation and cytotoxicity
[13]. NK cells were also found to be the major cellular source of IFNγ, a key cytokine in the
immune response to C. trachomatis infection [18]. Genetic susceptibility to early conjunctival
scarring is associated with polymorphism in NK cell receptors and host cell ligands [19]. Infec-
tion of epithelial cell lines with C. trachomatis render them susceptible to NK cell lysis and a
murine model of C. trachomatis infection found NK cell depletion to exacerbate the course of
infection [20,21,22].
Histological examination of trachomatous tissue gives a valuable opportunity to study the
disease. Several previous studies have examined the histopathology of conjunctival biopsy spec-
imens from individuals with trachoma [23,24,25,26,27,28,29,30,31,32,33]. However, these stud-
ies suffer from relatively small sample sizes and either lacked, or had very few, control samples
for comparison. We have analysed conjunctival biopsies from a larger number of patients with
trachomatous trichiasis and control subjects recruited from the same geographic region. We
characterised in detail the morphological and cellular changes using defined grading systems
with robust analytical techniques and observers masked to case-control status. We studied
whether the conjunctiva in trachomatous scarring is characterised by connective tissue changes
that can be seen histologically and with an increased inflammatory cell infiltrate. We also
wanted to examine the nature of this cellular infiltrate.
Methods
Ethical permission
This study adhered to the tenets of the Declaration of Helsinki. It was approved by the Tanza-
nian National Institute of Medical Research Ethics Committee, the Kilimanjaro Christian Med-
ical Centre Ethics Committee and the London School of Hygiene and Tropical Medicine Ethics
Committee. The study was explained to potential study subjects and written, informed consent
was obtained before enrolment.
Subject recruitment
Thirty-four individuals with trachomatous trichiasis (TT) were recruited from those undergo-
ing trichiasis surgery in the Kilimanjaro Region. Thirty-three comparison participants with
healthy tarsal conjunctiva were recruited from patients undergoing cataract or retinal detach-
ment surgery at Kilimanjaro Christian Medical Centre.
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Clinical assessment and swab sample collection
All subjects were examined by an ophthalmologist using ×2.5 loupes and a bright torch. The
1981 World Health Organization (FPC) trachoma grading system was used to grade conjuncti-
val follicles and papillae, entropion, trichiasis and corneal opacity [34]. A more detailed, previ-
ously described, grading system was used for conjunctival scarring [35,36]. Conjunctivae were
anaesthetised with preservative-free proxymetacaine 0.5% eye drops (Minims, Chauvin Phar-
maceuticals). Upper tarsal conjunctival swabs were collected (Dacron polyester-tipped, Hard-
wood Products Company, Guildford, ME) for C. trachomatis detection and put into a dry tube.
Samples were kept on ice packs until frozen later the same day at -80°C.
Biopsy samples and staining
Eyelids were injected with 2% lignocaine (Vital Healthcare, India) and eyes were cleaned with
5% povidone iodine. Biopsy samples were taken using a 3mm trephine from the tarsal conjunc-
tiva, 2mm from the lid margin, at the junction of the medial⅔ and lateral⅓ of the everted lid.
Samples were immediately placed in 10% neutral buffered formalin and subsequently embed-
ded in paraffin wax. Sections, 4 μm thick, were cut perpendicular to the conjunctival surface
and stained with hematoxylin and eosion (H&E) and by immunohistochemistry with the anti-
bodies shown in Table 1. Prior to immunohistochemical staining, sections were dewaxed and
pressure-cooked for 4 minutes in de-ionized water with antigen retrieval solution (Vector Lab,
UK). After incubation at room temperature with the primary antibody, sections were incubated
with a biotinylated secondary antibody, followed by streptavadin-conjugated horseradish per-
oxidase (Dako, UK), and finally 3,3’-diaminobenzidine (Dako, UK) was used as the chromo-
gen. Endogenous peroxidase was inhibited using Real Endogenous Peroxidase Block (Dako,
UK). The slides were counterstained with Harris hematoxylin. All staining procedures were
Table 1. Summary of primary antibody targets.
Target name Speciﬁcity Dilution Source and type
CD3 T-cell receptor complex1 1:400 Dako. polyclonal, rabbit. Code no. A.0452.
CD4 Helper T-cells2 1:50 Dako. Monoclonal, mouse. Clone 4B12.
CD8 Cytotoxic/suppressor T-cells3 1:100 Dako. Monoclonal, mouse. Clone C8/144B.
CD20 B-cells 1:600 Dako. Monoclonal, mouse. Clone L26.
CD45 Nucleated hematopoietic cells 1:800 Dako. Monoclonal, mouse. Clones 2B11+PD7/26.
CD56 Natural killer cells4 1:100 Dako. Monoclonal, mouse. Clone 123C.
CD68 Macrophages/monocytes 1:100 Dako. Monoclonal, mouse. Clone KP1.
CD83 Mature dendritic cells 1:75 Serotec AbD. Monoclonal, mouse. Clone HB15e.
NCR1 Natural killer cells 1:1000 Abcam. Monoclonal, mouse. Clone n1D9.
CD = Cluster Differentiation marker
Incubation times were 30 minutes for all antibodies
1 Natural killer cells also sometimes express CD3 and CD8.
2 Low levels of CD4 can also be expressed on other cell types including thymocytes, T cell lymphoma cells, cytotoxic/suppressor T cells, Kupffer cells and
dendritic cells.
3 13 C-terminal amino acids of cytoplasmic domain of human CD8α. 32 kDa polypeptide corresponding to CD8α. CD8 is expressed mostly as a αβ
heterodimer by a majority of thymocytes and by class l major histocompatibility complex restricted, mature, suppressor / cytotoxic T cells. A proportion of
γδ T cells and NK cells express the CD8 αα homodimer.*
4 Neural cell adhesion molecule 1 (NCAM1) (antibody recognizes a protein consisting of at least two subunits. NCAM is a membrane glycoprotein which
has multiple isoforms generated by alternative splicing from a single gene. The core polypeptide is the 140 kDa isoform which can be variably
glycosylated. The predominant isoform in NK and T cells is the transmembrane-anchored 140 kDa protein.
doi:10.1371/journal.pntd.0004734.t001
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performed using the Dako autostainer (Dako, UK). Positive control samples were provided by
human tonsil sections and omission of primary antibody controls were used throughout.
Microscopic examination of biopsy samples
Grading was performed by ophthalmic pathologists who were masked to the clinical status of
the patients. The grading was performed on the subepithelial tissue (lamina propria and stroma
unless otherwise stated) for the parameters below. Example images are shown in S1 Fig. The
degree of scarring was assessed using cross polarised light for both the subepithelial connective
tissue and the tarsus. Initial comparison of the examination of picrosirus red and other tinctorial
stains under cross polarised light showed that the organization of collagen bundles was apparent
with a variety of staining methods. For assessment purposes we used elastin/Van Gieson stained
preparations as these sections contained all of the samples available. Tissue appearing healthy
was graded as 0 and grades 1–3 used for progressive disorder of the normal appearance. Density
of inflammatory cell infiltrate was assessed using the H&E stained slides and an ordinal scale of
0–3 where 0 = scattered cells, 1 = few cells, 2 = moderate cells and 3 = abundant/confluent cells.
Immunohistochemistry was performed with the antibodies listed in Table 1. The whole of the
available section was examined and an ordinal scale of 0–3 was used where 0 = no/very few
cells, 1 = few cells, 2 = moderate cells and 3 = abundant/confluent cells.
Data analysis
Data were entered into Access 2007 (Microsoft) and analysed using STATA 11.0 (StataCorp
LP, TX). Fisher’s exact tests were used to determine the strength of association for the parame-
ters graded by case-control status.
Results
Study participants
Demographic and clinical characteristics of the participants are shown in Table 2. All cases had
tarsal conjunctival scarring with trichiasis, defined as at least one lash rubbing against the globe
or evidence of recent epilation. The majority of the cases were of Maasai ethnicity, while the
controls were more evenly divided between different ethnic groups. Clinically visible conjuncti-
val inflammation was very strongly associated with the presence of scarring. Lymphoid folli-
cles, which are the clinical hallmark of active disease in children, were not seen in any of the
participants. Infection with C. trachomatis was not detected in any of the participants. Surgery
was performed on the right eye of 14 (40%) of the cases and 19 (58%) of the controls.
Histological evidence of scarring
In healthy subepithelial tissue, short connective tissue fibres running parallel to the surface in
an ordered manner were observed. In healthy tarsal tissue long connective tissue fibres passing
between the meibomian glands, perpendicular to the mucosal surface, were seen. These termi-
nated in the shorter fibres running parallel to the surface, giving rise to a “T” configuration
[37]. On examination with cross polarised light all except one of the samples from control par-
ticipants had a visible “T-sign” in the tarsal connective tissue, while all of the cases had some
evidence of disorganisation of this appearance (Table 3).
Inflammatory cells
Cases had significantly more inflammatory cells than controls, assessed both with the H&E
and CD45 stains (Table 4). A number of sections were noted to have a marked inflammatory
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Table 2. Demographic and clinical characteristics.
Parameter Cases Controls p-value*
N = 34 N = 33
Demographic Characteristics
Female [n (%)] 22 (64.7) 15 (45.5) 0.09
Age in years [ū (95%CI)] 69.6 (65.6–73.6) 67.1 (62.1–72.1) 0.52
Ethnicity [n (%)] <0.001
Maasai 28 (82.3) 0 (0.0)
Chagga 4 (11.8) 14 (42.4)
Pare 0 (0.0) 8 (24.2)
Other 2 (5.9) 11 (33.3)
Any education [n (%)] 4 (12.5) 26 (86.7) <0.001
Clinical Characteristics
Scarring grade [n (%)]
S0 - - 33 (100)
S1a 0 0 - -
S1b 0 0 - -
S1c 6 (17.7) - -
S2 5 (14.7) - -
S3 23 (68.6) - -
Papillary inﬂammation grade [n (%)] <0.001
P0 4 (11.8) 31 (93.9)
P1 5 (14.7) 1 (3.0)
P2 18 (52.9) 1 (3.0)
P3 7 (20.6) 0 (0.0)
* Using the Fisher’s exact test, and the Wilcoxon ranked sum test for age.
doi:10.1371/journal.pntd.0004734.t002
Table 3. Connective tissue scarring grade using polarised light.
Scarring grade Cases Controls p-value*
n (%) n (%)
Subepithelial tissue N = 29 N = 31 <0.001
0 3 (10.3) 26 (83.9)
1 13 (44.8) 5 (16.1)
2 12 (41.4) 0 (0.0)
3 1 (3.5) 0 (0.0)
Tarsal tissue N = 13† N = 32 <0.001
0 0 (0.0) 31
1 5 (38.5) 0 (0.0)
2 6 (46.1) 1 (3.1)
3 2 (15.4) 0 (0.0)
* Using Fishers’ exact test.
† Insufﬁcient tarsal tissue limited the number available for grading.
doi:10.1371/journal.pntd.0004734.t003
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cell infiltrate in which a large proportion of the cells were CD45 negative (Fig 1). The inflam-
matory cell infiltrate was also analysed in relation to the presence of clinical inflammation
(with significant inflammation defined as grades P2/3 and non-significant inflammation as
grades P0/1). There was more infiltrate and CD45 staining in individuals with clinical inflam-
mation (P2/3). However, if this analysis is restricted to cases only, there was no significant dif-
ference for inflammatory cell infiltrate by H&E (p = 0.59) or CD45+ cell infiltrate by IHC
(p = 0.38) in inflamed vs non-inflamed cases (although the number of non-inflamed cases was
small, n = 9). The inflammatory cell infiltrates were more marked in non-inflamed cases com-
pared to non-inflamed controls, for both the H&E stained sections (p = 0.005) and CD45
+ IHC stained sections (p = 0.001).
Table 4. Inflammatory cell infiltrates.
Parameter Cases Controls p-value*
n (%) n (%)
H&E inﬂammatory inﬁltrate N = 32 N = 33 <0.001
0 0 (0.0) 16 (48.5)
1 15 (46.9) 14 (42.4)
2 8 (25.0) 3 (9.1)
3 9 (28.1) 0 (0.0)
IHC CD45+ cells N = 34 N = 33 <0.001
0 6 (17.7) 21 (63.6)
1 11 (32.3) 11 (33.3)
2 9 (26.5) 0 (0.0)
3 8 (23.5) 1 (3.0)
* Using Fisher’s exact test.
doi:10.1371/journal.pntd.0004734.t004
Fig 1. Conjunctival sections after staining for CD45. Some CD45 positive cells, stained brown, can be observed. However, many CD45 negative
inflammatory cells can also be seen. Original magnification ×400.
doi:10.1371/journal.pntd.0004734.g001
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Characterisation of infiltrating cell immunophenotype by
immunohistochemical cell staining
Cases had significantly more CD8+, CD56+ and CD20+ cells than controls (Table 5). More
than half of the cases had moderate levels of CD8+ cells compared to very few of the controls
(p = 0.001, none of the sections were graded as 3). Almost a third of the cases had moderate lev-
els for CD56+ cells compared to none of the controls (p = 0.001). No sections stained for CD8
Table 5. Presence of immune cell markers and phenotypes by immunohistochemistry.
Cellular stain Cases Controls p-value*
n (%) n (%)
CD3 N = 33 N = 33 0.06
0 16 (48.5) 20 (60.6)
1 12 (36.4) 13 (39.4)
2 5 (15.1) 0 (0.0)
3 0 (0.0) 0 (0.0)
CD4 N = 33 N = 32 0.36
0 10 (30.3) 6 (18.8)
1 19 (57.6) 24 (75.0)
2 4 (12.1) 2 (6.2)
3 0 (0.0) 0 (0.0)
CD8 N = 33 N = 32 0.001
0 0 (0.0) 1 (3.1)
1 14 (42.4) 27 (84.4)
2 19 (57.6) 4 (12.5)
3 0 (0.0) 0 (0.0)
CD20 N = 32 N = 33 0.03
0 8 (25.0) 13 (39.4)
1 10 (31.3) 16 (48.5)
2 10 (31.3) 4 (12.1)
3 4 (12.5) 0
CD56 N = 20† N = 31 0.001
0 8 (40.0) 10 (32.3)
1 6 (30.0) 21 (67.7)
2 6 (30.0) 0 (0.0)
3 0 (0) 0 (0)
CD68 N = 33 N = 33 0.33
0 23 (69.7) 23 (69.7)
1 10 (30.3) 8 (24.2)
2 0 (0.0) 2 (6.1)
3 0 (0.0) 1 (0.0)
CD83 N = 32 N = 33 0.68
0 6 (18.8) 8 (24.2)
1 16 (50.0) 16 (48.5)
2 10 (31.2) 8 (24.2)
3 0 (0.0) 1 (3.0)
* Using Fisher’s exact test.
† A number of the sections were no longer available for CD56 staining owing to limited sample.
doi:10.1371/journal.pntd.0004734.t005
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or CD56 reached grade 3. Almost half of the cases had moderate or confluent levels for CD20
+ cells compared to very few of the controls (p = 0.03). Of borderline statistical significance,
cases had marginally more CD3+ cells than controls. There was a significant association
between the presence of CD8+ and CD56+ cells (Table 6). Neutrophils (which are generally
easily recognised on histological sections without specific immunohistochemical staining) were
very infrequent in either cases or controls and therefore no formal grading was undertaken.
Natural cytotoxicity triggering receptor 1 (NCR1) staining was undertaken after the initial
analysis, when there were only a limited number of sections remaining, constraining the analy-
sis to a more qualitative nature. Of those that were stained, however, NCR1+ cells were found
more commonly in cases and in those samples where CD56+ cells were present (Fig 2). NCR1
staining using an appendix specimen as a control sample is shown in S2 Fig for comparison.
Discussion
In this study we have characterised in detail the morphological and cellular changes found in
trachomatous scarring. Scarring was associated with marked infiltrates of CD8+ and CD56
+ cells, compared to controls. CD56, used in conjunction with other markers such as the pan-T
cell marker CD3, is used to identify NK cells, which are regarded as CD3- CD56+ [15,16,38].
NK cells lack a single defining genetic or phenotypic characteristic and share considerable
Table 6. Comparison of CD8 and CD56 cellular grades.
CD56
0 1 2 Total
0 1 0 0 1
CD8 1 12 20 1 33
2 5 7 5 17
Total 18 27 6 51
Fisher’s exact test = 0.03
doi:10.1371/journal.pntd.0004734.t006
Fig 2. Conjunctival sections from two patients with trichiasis after staining for NCR1.Numerous NCR1 positive cells, stained brown, can be seen.
Original magnification ×200.
doi:10.1371/journal.pntd.0004734.g002
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overlap with cytotoxic CD8+ T-cells; the CD8 antigen is expressed by both T-cells and NK
cells [38]. If the CD8+ stained cells were T-cells they would be expected to co-express CD3.
However, we found a marked lack of CD3+ cells relative to CD8+ cells. This suggests that the
increased CD8+ cells found in scarred conjunctiva may not be T-cells, lending weight to the
possibility that they may be NK cells. This possibility is further supported by a significant asso-
ciation between CD8+ and CD56+ infiltrates, Table 6 (p = 0.03 with Fisher’s exact test). Addi-
tional staining for NCR1 in a more limited number of samples was also consistent with an
increased presence of NK cells in scarred cases. These results overall support the hypothesis
that scarred conjunctiva in trachoma contains a prominent NK cell infiltrate. To more defini-
tively confirm this phenotype double antibody staining techniques, which present considerable
technical difficulties in limited ocular samples, would be required.
While the results of the present study require confirmation, the data suggests that NK cells
were increased in the conjunctivae of trichiasis cases and thus may be important in the devel-
opment of scarring complications. Combinations of CD3-, CD56+, CD8+ and NCR1+ IHC
staining have previously been used for the identification of NK cells in lymph nodes, colorectal
cancer tissue and in the gut mucosa of HIV infected individuals [39,40,41]. Recently, a form of
NK cell memory-like responses that contribute to the effector phase of vaccine-induced adap-
tive immune responses or display heightened responses following repeated challenge infections
have been identified [42,43]. Repeated C. trachomatis infection may cause a pathological NK
cell response resulting in tissue damage either through a direct cytolytic effect or through the
production of cytokines and related molecules. This is consistent with recent studies pointing
towards the importance of innate immune responses in the pathogenesis of trachoma and war-
rants further investigation into the role of NK cells [11,13,14].
Some of the findings in our study contrast with two previous immunohistological studies on
biopsy samples from subjects with trachomatous scarring. Both found increased T-cell popula-
tions in scarred tissue and suggested that in inflamed cases these were predominantly CD4+ T-
cells and in non-inflamed cases predominantly CD8+ T-cells [24,26]. However, these studies
had a number of methodological and analytical differences which may explain the discrepancy
with our conclusions. The first study recruited only three control participants whose demo-
graphic details were not presented; the grading system used was not defined; only limited data
was presented and no significance testing was performed [24]. The second study appears to
have been performed in a non-trachoma endemic region; it also utilised only three control
samples which were collected post-mortem; cases were divided into inflamed or non-inflamed
on the basis of the number of immunohistochemically stained cells present in relation to con-
trol samples (rather than clinical status); relatively limited data and no tests for significance
were performed [26]. Other studies looking at cell populations in trachomatous scarring have
not included control tissue or presented quantitative data [23,31].
We also found evidence that trachomatous scarring is associated with increased numbers
of CD20+ B-cells. Anti-chlamydial antibodies have been found in tears and sera of both chil-
dren with active disease and adults with scarring [44,45,46,47]. Whether these are protective,
or simply markers of previous infection, is not known. In contrast, animal models of genital
tract infection support the role of humoral immunity in protection against re-infection
[48,49,50,51].
We found no evidence suggestive of increased T-helper cells (CD4+), macrophages (CD68
+) or neutrophils in cases of scarring. The presence of neutrophils tends to be transient and it
is possible that a significant neutrophil presence may not have been detected by our analysis.
There was also no difference in the levels of cells expressing CD83+, a marker of mature den-
dritic cells. However, dendritic cell immunophenotyping is more complex than definitive iden-
tification of NK cells. Dendritic cell characterisation normally requires a combination of
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staining intensity coupled with positive and negative markers. This was beyond the scope of
this study owing to the limited amount of biopsy tissue and the total number of immunohisto-
chemical markers used.
A marked inflammatory cell infiltrate was seen in biopsies from individuals with scarring
which could not be accounted for by the specific stains and increased numbers of CD8+, CD56
+ and CD20+ cells. It was also notable that in a number of cases there were numerous CD45
negative inflammatory/immune cells present. Based on previous studies we expected most or
all of the inflammatory cells present to be CD45+. CD45 is expressed on nearly all nucleated
cells of hematopoietic origin [52]. The identity of these CD45 negative cells infiltrating scarred
tissue remains an enigma. However, one of several potential explanations might be the pres-
ence of follicular dendritic cells, which are non-hematopoietic in origin and associated with
lymphoid follicle formation [53,54].
Conjunctival inflammation is probably on the causal pathway to the development and pro-
gression of scarring complications in trachoma and we found the presence of scarring to be
very strongly associated with clinical inflammation [4,55,56,57,58,59]. Of interest, our data
showed that cases with more clinical inflammation did not have increased histological cellular
infiltrates compared to cases with less clinical inflammation. These clinically non-inflamed
cases did, however, have more cellular infiltrate compared to clinically non-inflamed controls.
While there were small numbers involved in these comparisons, they suggest that scarring is
associated with ongoing inflammatory/immune cell infiltration, even in the absence of a clini-
cally apparent inflammatory episode characterised by hyperaemia and papillary reaction. The
observation that an increased number of inflammatory cells were present in non-clinically
inflamed trichiasis cases relative to controls was also observed in a parallel IHC study with a
total of 36 samples, supporting this theory (Tamsyn Derrick, personal communication).
This study benefitted from a larger number of age-matched control participants than previ-
ous studies. The socio-demographic background of the controls differed to a degree from the
cases, as reflected in the different educational levels and ethnicity. However, many controls
were identified through outreach programmes in rural areas where trachoma is typically found
and most had the cost of their surgery subsidised. Identifying unaffected control subjects with
completely identical backgrounds to scarred trachoma cases is challenging as often the majority
of older adults have some conjunctival scarring in endemic areas. The inclusion of control par-
ticipants has allowed us to compare the normal pattern of conjunctival immune cells to that
found in scarring trachoma. This comparison is essential for interpretation of diseased tissue,
especially in the geographic regions where trachoma is found since these tend to have a rela-
tively high prevalence of conjunctival non-chlamydial bacterial infection [35,60].
Earlier studies of conjunctival cell populations in healthy individuals have found that
inflammatory / immune cells are normally present. T-cells are the most abundant cell type,
with B-cells, macrophages, NK cells, neutrophils and dendritic cells also present [61,62,63,64].
Varying proportions of CD4+ and CD8+ cells have been reported, but with roughly overall
equal numbers [61,62,63,64]. A slight predominance of CD8+ cells in the tarsal stroma was
previously reported, and this is consistent with what we observed in controls.
Quantification of tarsal conjunctival scarring is not straight-forward with a paucity of robust
grading systems in the literature. As part of these studies we developed a new system for grad-
ing both the sup-epithelial and tarsal connective tissue using cross-polarised light [37]. This
allowed us to directly visualise collagen fibres and the grading closely corresponded to the clini-
cal status. The association was particularly strong for grading the tarsal connective tissue where
the fibres were longer and could be more easily visualised.
In conclusion, our study found evidence most consistent with a NK cell infiltrate in scarring
trachoma and lends further support to studies implicating innate immune responses in the
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pathogenesis of trachoma. Scarred tissue was also infiltrated by large numbers of CD45 nega-
tive cells, which require further work to be characterised.
Supporting Information
S1 Fig. Example images for conjunctival histological grading. The top row shows grade 0
and the bottom row grade 3 (where available). A—CD3; B- CD4; C—CD8; D—CD20; E—
CD45; F—CD56; G—CD68; H—CD83. Original magnification ×200.
(TIFF)
S2 Fig. Control image from an appendix specimen.Original magnification ×200.
(TIFF)
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